These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38673808)

  • 1. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
    Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
    Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
    Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.
    Bagley SJ; Nabavizadeh SA; Mays JJ; Till JE; Ware JB; Levy S; Sarchiapone W; Hussain J; Prior T; Guiry S; Christensen T; Yee SS; Nasrallah MP; Morrissette JJD; Binder ZA; O'Rourke DM; Cucchiara AJ; Brem S; Desai AS; Carpenter EL
    Clin Cancer Res; 2020 Jan; 26(2):397-407. PubMed ID: 31666247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
    Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
    Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
    Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis.
    Palande V; Siegal T; Detroja R; Gorohovski A; Glass R; Flueh C; Kanner AA; Laviv Y; Har-Nof S; Levy-Barda A; Viviana Karpuj M; Kurtz M; Perez S; Raviv Shay D; Frenkel-Morgenstern M
    Mol Oncol; 2022 May; 16(10):2098-2114. PubMed ID: 34875133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
    Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.
    Fontanilles M; Marguet F; Beaussire L; Magne N; Pépin LF; Alexandru C; Tennevet I; Hanzen C; Langlois O; Jardin F; Laquerrière A; Sarafan-Vasseur N; Di Fiore F; Clatot F
    Acta Neuropathol Commun; 2020 Nov; 8(1):179. PubMed ID: 33148330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
    Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
    Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA).
    Mehra N; Dolling D; Sumanasuriya S; Christova R; Pope L; Carreira S; Seed G; Yuan W; Goodall J; Hall E; Flohr P; Boysen G; Bianchini D; Sartor O; Eisenberger MA; Fizazi K; Oudard S; Chadjaa M; Macé S; de Bono JS
    Eur Urol; 2018 Sep; 74(3):283-291. PubMed ID: 29500065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.
    Duan X; Yang B; Zhao C; Tie B; Cao L; Gao Y
    BMC Cancer; 2023 May; 23(1):432. PubMed ID: 37173662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme.
    Bennett IE; Guo H; Kountouri N; D'abaco GM; Hovens CM; Moffat BA; Desmond P; Drummond K; Kaye AH; Morokoff AP
    J Clin Neurosci; 2015 Nov; 22(11):1802-8. PubMed ID: 26308396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme.
    Lopes M; Carvalho B; Vaz R; Linhares P
    J Neurooncol; 2018 Jan; 136(1):173-180. PubMed ID: 29076002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of circulating DNA in malignant neoplasia from diverse locations: Investigating a diagnostic role.
    Kumari S; Mishra S; Husain N; Verma T; Tiwari V; Kaif M; Agarwal A; Rastogi M; Shukla S; Sonkar AA
    Indian J Pathol Microbiol; 2022; 65(1):93-99. PubMed ID: 35074971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples.
    Huang Y; Mu J; Qi L; Ge W; Fang X; Song Y; Yuan Y; Zheng S
    Clin Chem Lab Med; 2020 Aug; 58(9):1451-1459. PubMed ID: 32229658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
    Yu Z; Qin S; Wang H
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of plasma d-dimer levels in patients with glioblastoma multiforme - Results from a pilot study.
    Hoke M; Dieckmann K; Koppensteiner R; Schillinger M; Marosi C; Mlekusch W
    Wien Klin Wochenschr; 2011 Apr; 123(7-8):199-203. PubMed ID: 21442202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis.
    Ponti G; Maccaferri M; Manfredini M; Micali S; Torricelli F; Milandri R; Del Prete C; Ciarrocchi A; Ruini C; Benassi L; Bettelli S; Kaleci S; Ozben T; Tomasi A
    Clin Chim Acta; 2019 Oct; 497():76-80. PubMed ID: 31301282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.